Home/Publication/Sequoia, Unicorn Capital et al Join Lilly Asia & Zoo Capital in Biopharma Play in the US
Sequoia, Unicorn Capital et al Join Lilly Asia & Zoo Capital in Biopharma Play in the US
28 Mar 2023
US$ 0.00
Related Publications
True North LLP has pared down its stake in India-listed Niva Bupa Health Insurance Co Ltd (Niva Bupa) and clocked 14.3...
Copenhagen Infrastructure Partners (CIP) is to divest a 25% interest in the San Miguel Bay Offshore Wind Power ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.